Ainara Soria
Hospital Universitario Ramon y Cajal
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ainara Soria as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:28 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06906822 · PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma PatientsGrupo Español Multidisciplinar de Melanoma · active not recruiting · Melanoma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:28 UTC. The ranking covers the 200 most relevant of 24 PubMed records, and a shared surname and initials can bring in a namesake. All 24 on PubMed
- 1,444 citationsRCR 57.6
- Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study.Lancet Respir Med · 2020343 citationsRCR 18.2
- Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer.Breast Cancer Res Treat · 199641 citationsRCR 1.0
- Immunomodulatory effects of the intake of fermented milk with Lactobacillus casei DN114001 in lactating mothers and their children.Br J Nutr · 200840 citationsRCR 1.3
- Treatment of refractory oral erosive lichen planus with topical rapamycin: 7 cases.Dermatology · 200939 citationsRCR 1.6
- 39 citationsRCR 1.3
- Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination.J Clin Invest · 201937 citationsRCR 1.3
- Combined therapy of insulin and tolazamide decreases insulin requirement and serum triglycerides in obese patients with noninsulin-dependent diabetes mellitus.Am J Med Sci · 198720 citationsRCR 0.9
- Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study).Neuro Oncol · 202420 citationsRCR 2.0
- 18 citationsRCR 0.9